Pregabalin for generalised anxiety disorder.
Generalised anxiety disorder (GAD) is common, with a prevalence of around 4% among adults in the UK. The condition is characterised by chronic excessive anxiety and worry, in combination with a variety of psychological or somatic symptoms. It can be very distressing and disabling and, if left untreated, can be costly to both the individual and society. Pregabalin (Lyrica - Pfizer) is a medicine licensed for GAD in adults. Here we review its role in the management of patients with the problem.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D006801:Humans; D015201:Meta-Analysis as Topic; D056687:Off-Label Use; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid